TRV GP III, LLC
- SEC CIK
- 0001637299
- Latest filing
- Feb 14, 2024
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 5
- −1 vs. Q3 2022
- Portfolio value
- $127.6M
- −$101.4M (−44.3%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RVMDRevolution Medicines, Inc. | COM | 1,604,130 | $38.2M | 29.9% | −2,000,000−55.5% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 1,839,160 | $35.6M | 27.9% | −2,000,000−52.1% | Reduced | History |
| VYGRVoyager Therapeutics, Inc. | COM | 5,428,933 | $33.1M | 26.0% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 1,962,202 | $14.3M | 11.2% | −2,000,000−50.5% | Reduced | History |
| DBTXDecibel Therapeutics, Inc. | COM | 3,139,685 | $6.44M | 5.0% | 00.0% | Unchanged | History |
Sold out since Q3 2022 (1)
Positions held at the end of Q3 2022 that are gone from this filing.